Member Info for Computer909

A year to the day (3/9/2020) since ODX CE marked their first covid test, and 8 over month since Mologic CE marked their Antigen test, and ODX have successfully sold 175k tests that have yet to be paid for.

Truly transformational !!!

"I wonder what CK is discussing as his been discussing for as long as I can remember"

Latest transcript of CK's dialogue with DHSC
https://www.playphrase.me/#/search?q=business+deal+has+to+be+put+on+hold

https://www.playphrase.me/#/search?q=do+nothing+but+talk

https://www.gov.uk/government/publications/dhsc-spending-over-25000-july-2021

£103M paid to Tanner Pharma for Orient Gene rapid Tests
No further payment to Innova

@RegulatorUK: "I would assume that's more to do with your inability to get an interview in the first place"

I assume you never had to interview for the role of the NHS' resident clown !

"otherwise he might send an extract down to HR"

You might get a visit from the ODX enforcer aka BigJock

@Sledgey121: As an investor in multiple companies, i have never yet felt the need to smuggle myself into a job interview with a company, to actually see if they were doing anything !

So we have gone from the secret filming by sleuth dog walkers in Alva, to the undercover reconnaissance via the infiltration of a job interview in Littleport, this has to be a new low in investor relations/communications, even for ODX

Perhaps a good question would be, how they keep the cobwebs off the equipment that has been sat idle for 18 months ?

@Okehurst1: “£8M a year gross , all helps , not to be sniffed at”

True enough, but not the transformational change we have been led to believe will be happening at ODX,

If they can sell 100m a year that would be the achievement we are all looking for, but todays tweet looks more like a “don't forget we will return to business as usual post pandemic, my concern would be are they adjusting to a moving playing field, with CHAI moving for Mologic will that market become diluted, is the CD4 test covered by any patent protection or can others launch a competing product?

Cant see ODX being taken over, what IP do they have that is worth nearly £100m, if any LFT manufacturer was the target for takeover its more likely to be ABDX

This is old news we have discussed before

https://www.brrmedia.co.uk/broadcasts/5f84724bc4d0076f2b93e3c5/omega-diagnostics-group-product-sector-overview-cd4/
@3.55

CD4 is no where near going to support the current mcap, as John Bannister says Omega should be positioned to supply 4-6M tests per year in the next 3-5 years, at a supply cost of $4 per test”

Not sure why Colin thought to make such a point needing to reiterate again

"A bit like a few odd family members"

More like the Munsters !

"at least she should drag us up today"

Not sure why you think a direct competitor in the LFT contract manufacturing market announcing a new contract will "drag us up" ?

It looks like ABDX may produce a game changing score card product using the ABC-19 Assay which if cheap enough could be the product that defines how we deal with vaccination boosters, ie we test regularly at home and then get a booster if we don't reach a particular score.

The concern for ODX is that they haven't mentioned (either via RNS or twitter) any involvement in that product so we assume that ABDX will go it alone with that product, at least until they max out their capacity?

If you check the latest published accounts we know exactly what the 172 staff from the global health division are making….

Making a loss of £2.2M

"It's goin back up..SOOON !"

ODX have made an art out of redefining imminently !

"Bargain Bargain Bargain Bargain...."

We thought we were getting a bargain in the placing at 40p a massive 27% discount on the 55p price at the time, turns out not to have been such a bargain after all, if this slips into the 30's without any support from the company, News on Regulator submission, Actual progress rather than just talking with DHSC or 3rd parties, or actual progress in sales and marketing, then surely then Colins time must be coming to an end, and he has to consider his position.

"Our focus will be on the 2m tests a week capacity"

Perhaps some one should tell him to focus on delivery or sales rather than capacity !

"Innova contract winds down next week"

Seem to have heard that before somewhere ?

"If the company help to save lives then that's a good thing money is irrelevant lives"

A very admirable approach, if you are backed by the likes of Clinton etc with very deep pockets, unfortunately for the others if the company wants to continue to operate and save lives they are going to have to start making some money.

As we approach the placing price, everyone surely is asking what the hell have they done since we gave them £11M to work with, apart from pay off the overdraft that is !

"We have had confirmation of Covid related sales in Q4 2020/21."

£932K ABC-19 tests (we haven't been paid for yet)
£468K Sub-contracts
£268K ELISA Antibody

122 Staff "Producing" a loss of £2.2M

"Visitect is also on sale in the UK and getting orders."

Can you share a link ?